Literature DB >> 21563175

Interactive effects of fatty acid and butyrate-induced mitochondrial Ca²⁺ loading and apoptosis in colonocytes.

Satya Kolar1, Rola Barhoumi, Chris K Jones, Joshua Wesley, Joanne R Lupton, Yang-Yi Fan, Robert S Chapkin.   

Abstract

BACKGROUND: The combination of fish oil-derived docosahexaenoic acid (DHA) (22:6; omega 3 [n-3]) and butyrate (4:0), a fiber fermentation product, synergized to enhance colonocyte apoptosis by inducing a p53-independent, oxidation sensitive, mitochondrial Ca(2+) -dependent (intrinsic) pathway.
METHODS: In this study, the authors probed the specificity of n-6 and n-3 polyunsaturated fatty acid induction of Ca(2+) -dependent proapoptotic events in immortalized young adult mouse colonocytes and determined whether combinations of polyunsaturated fatty acid and butyrate could trigger endoplasmic reticulum (ER) stress conditions, thereby promoting mitochondrial Ca(2+) overload. Cultures were treated with 0 μM to 50 μM of DHA (22:6; n-3), EPA (20:5; n-3), arachidoinic acid (AA) (20:4; n-6), linoleic acid (18:2; n-6), or oleic acid (OA) (18:1; n-9) for a total of 72 hours with or without RU-360 (to inhibit the mitochondrial Ca(2+) uniporter) for 30 minutes before cotreatment with butyrate (0 mM or 5 mM).
RESULTS: Combined DHA and butyrate maximally induced apoptosis and mitochondrial-to-cytosolic Ca(2+) levels. By comparison, EPA, a precursor to DHA, was minimally effective. Similarly, AA and OA in combination with butyrate had no effect on mitochondrial Ca(2+) or apoptosis compared with butyrate alone. DHA with or without butyrate cotreatment minimally altered the ER stress-regulated genes DNA damage-inducible transcript 3, the CCAAT enhancer binding protein (C/EBP) homologous protein (CHOP), and eukaryotic initiation factor 2α.
CONCLUSIONS: The current data indicated that butyrate and DHA, but not EPA, worked in a coordinated fashion to trigger an ER-independent, Ca(2+) -dependent, intrinsic mitochondrial-mediated apoptotic pathway in colonocytes.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21563175      PMCID: PMC3156959          DOI: 10.1002/cncr.26205

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  45 in total

1.  Upregulation of p21Waf1/Cip1 expression in vivo by butyrate administration can be chemoprotective or chemopromotive depending on the lipid component of the diet.

Authors:  Kristy Covert Crim; Lisa M Sanders; Mee Young Hong; Stella S Taddeo; Nancy D Turner; Robert S Chapkin; Joanne R Lupton
Journal:  Carcinogenesis       Date:  2008-06-20       Impact factor: 4.944

Review 2.  Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine.

Authors:  Robert S Chapkin; Jeongmin Seo; David N McMurray; Joanne R Lupton
Journal:  Chem Phys Lipids       Date:  2008-03-04       Impact factor: 3.329

3.  Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid.

Authors:  Md Mizanur Rahman; Arunabh Bhattacharya; Gabriel Fernandes
Journal:  J Cell Physiol       Date:  2008-01       Impact factor: 6.384

4.  Proapoptotic effects of dietary (n-3) fatty acids are enhanced in colonocytes of manganese-dependent superoxide dismutase knockout mice.

Authors:  Yang-Yi Fan; Yang Zhan; Harold M Aukema; Laurie A Davidson; Lan Zhou; Evelyn Callaway; Yanan Tian; Brad R Weeks; Joanne R Lupton; Shinya Toyokuni; Robert S Chapkin
Journal:  J Nutr       Date:  2009-05-20       Impact factor: 4.798

Review 5.  Differential regulation of the ER stress response by long-chain fatty acids in the pancreatic beta-cell.

Authors:  Eleftheria Diakogiannaki; Noel G Morgan
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

6.  A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men.

Authors:  Megan N Hall; Jorge E Chavarro; I-Min Lee; Walter C Willett; Jing Ma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

7.  Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress.

Authors:  Mounia Chami; Bénédicte Oulès; György Szabadkai; Rachida Tacine; Rosario Rizzuto; Patrizia Paterlini-Bréchot
Journal:  Mol Cell       Date:  2008-12-05       Impact factor: 17.970

8.  Docosahexaenoic acid and butyrate synergistically induce colonocyte apoptosis by enhancing mitochondrial Ca2+ accumulation.

Authors:  Satya Sree N Kolar; Rola Barhoumi; Joanne R Lupton; Robert S Chapkin
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

9.  c-Jun inhibits thapsigargin-induced ER stress through up-regulation of DSCR1/Adapt78.

Authors:  Peng Zhao; Xiaoyan Xiao; Agnes S Kim; M Fatima Leite; Jinxia Xu; Xinglei Zhu; Jun Ren; Ji Li
Journal:  Exp Biol Med (Maywood)       Date:  2008-07-18

10.  DHA induces ER stress and growth arrest in human colon cancer cells: associations with cholesterol and calcium homeostasis.

Authors:  Caroline Hild Jakobsen; Gro Leite Størvold; Hilde Bremseth; Turid Follestad; Kristin Sand; Merete Mack; Karina Standahl Olsen; Anne Gøril Lundemo; Jens Gustav Iversen; Hans Einar Krokan; Svanhild Arentz Schønberg
Journal:  J Lipid Res       Date:  2008-06-19       Impact factor: 5.922

View more
  18 in total

Review 1.  Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.

Authors:  Tim Y Hou; Laurie A Davidson; Eunjoo Kim; Yang-Yi Fan; Natividad R Fuentes; Karen Triff; Robert S Chapkin
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

Review 2.  The microbiome and colorectal neoplasia: environmental modifiers of dysbiosis.

Authors:  N D Turner; L E Ritchie; R S Bresalier; R S Chapkin
Journal:  Curr Gastroenterol Rep       Date:  2013-09

Review 3.  Omega-3 fatty acids, membrane remodeling and cancer prevention.

Authors:  Natividad R Fuentes; Eunjoo Kim; Yang-Yi Fan; Robert S Chapkin
Journal:  Mol Aspects Med       Date:  2018-04-12

4.  Chemoprotective epigenetic mechanisms in a colorectal cancer model: Modulation by n-3 PUFA in combination with fermentable fiber.

Authors:  Karen Triff; Eunjoo Kim; Robert S Chapkin
Journal:  Curr Pharmacol Rep       Date:  2015-02

5.  Dietary fat and fiber interact to uniquely modify global histone post-translational epigenetic programming in a rat colon cancer progression model.

Authors:  Karen Triff; Mathew W McLean; Evelyn Callaway; Jennifer Goldsby; Ivan Ivanov; Robert S Chapkin
Journal:  Int J Cancer       Date:  2018-05-10       Impact factor: 7.396

Review 6.  Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Authors:  Allen K Greiner; Rao V L Papineni; Shahid Umar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-01       Impact factor: 4.052

Review 7.  Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization.

Authors:  Natividad R Fuentes; Michael L Salinas; Eunjoo Kim; Robert S Chapkin
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-03-22       Impact factor: 3.747

8.  A chemoprotective fish oil/pectin diet enhances apoptosis via Bcl-2 promoter methylation in rat azoxymethane-induced carcinomas.

Authors:  Youngmi Cho; Nancy D Turner; Laurie A Davidson; Robert S Chapkin; Raymond J Carroll; Joanne R Lupton
Journal:  Exp Biol Med (Maywood)       Date:  2012-12

9.  Colon cancer cell apoptosis is induced by combined exposure to the n-3 fatty acid docosahexaenoic acid and butyrate through promoter methylation.

Authors:  Youngmi Cho; Nancy D Turner; Laurie A Davidson; Robert S Chapkin; Raymond J Carroll; Joanne R Lupton
Journal:  Exp Biol Med (Maywood)       Date:  2014-02-04

10.  Detecting Multivariate Gene Interactions in RNA-Seq Data Using Optimal Bayesian Classification.

Authors:  Jason M Knight; Ivan Ivanov; Karen Triff; Robert S Chapkin; Edward R Dougherty
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2015-10-01       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.